: Control the flow of ions across membranes.

: Drugs that bind to and activate a receptor, mimicking natural signaling molecules.

Beyond receptors, drugs may also target enzymes (such as NSAIDs inhibiting cyclooxygenase), transporters, or ion channels directly. Agonists, Antagonists, and Affinity

: Refers to how tightly a drug binds to its receptor, measured by the dissociation constant ( Kdcap K sub d ). A smaller Kdcap K sub d

Drugs do not typically create new biological functions; instead, they modify existing biochemical processes. Most drugs achieve this by binding to specific target structures, primarily —specialized proteins on cell surfaces or within cells.

In conclusion, pharmacodynamics provides the scientific framework for understanding drug efficacy and safety. By mapping how molecules interact with cellular machinery, clinicians can better predict therapeutic outcomes and tailor treatments to individual patient needs. Pharmacodynamics - StatPearls - NCBI Bookshelf - NIH

: Drugs that bind to a receptor but do not activate it, effectively blocking other molecules from binding.

Central to pharmacodynamics is the , which quantifies how the intensity of an effect changes with varying drug concentrations. This is typically visualized using a concentration-response curve. Key metrics include: Emaxcap E sub m a x end-sub : The maximal effect a drug can produce regardless of dose. EC50cap E cap C sub 50